CA2121603A1
(en)
*
|
1991-11-15 |
1993-05-16 |
Hirohisa Okuyama |
Antiphlogistic-analgesic plaster
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
DE4231493A1
(de)
*
|
1992-09-21 |
1994-03-24 |
Nordmark Arzneimittel Gmbh |
Verfahren zur Herstellung von Pellets aus einem Ephedrinderivat
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
JP2920451B2
(ja)
*
|
1993-03-29 |
1999-07-19 |
エスエス製薬株式会社 |
消炎鎮痛貼付剤
|
SE9301220D0
(sv)
*
|
1993-04-14 |
1993-04-14 |
Kabi Pharmacia Ab |
Manufacturing matrices
|
IL109460A
(en)
|
1993-05-10 |
1998-03-10 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
GB9518465D0
(en)
|
1995-09-09 |
1995-11-08 |
Smithkline Beecham Seiyaku Kk |
Pharmaceuticals
|
US6013272A
(en)
*
|
1996-12-19 |
2000-01-11 |
Valent U.S.A. Corporation |
Chemically stable, insecticidally active phosphoroamidothioate pellet compositions and methods for their manufacture
|
US6013280A
(en)
*
|
1997-10-07 |
2000-01-11 |
Fuisz Technologies Ltd. |
Immediate release dosage forms containing microspheres
|
AU7963698A
(en)
*
|
1998-06-11 |
1999-12-30 |
Oms Investments, Inc. |
Water soluble fertilizer compositions and processes for their preparation
|
DK1104289T3
(da)
*
|
1998-08-21 |
2006-05-15 |
Novartis Ag |
Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
|
US6821456B2
(en)
*
|
1998-09-22 |
2004-11-23 |
Albemarle Corporation |
Granular polymer additives and their preparation
|
US6800228B1
(en)
|
1998-09-22 |
2004-10-05 |
Albemarle Corporation |
Sterically hindered phenol antioxidant granules having balanced hardness
|
US6056898A
(en)
*
|
1998-09-22 |
2000-05-02 |
Albemarle Corporation |
Low dust balanced hardness antioxidant pellets and process for the production of same
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
US6391238B1
(en)
*
|
1998-11-13 |
2002-05-21 |
Kabushiki Kaisha Toshiba |
Method of producing algae cultivating medium
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
DE19921549A1
(de)
*
|
1999-05-11 |
2000-11-16 |
Merck Patent Gmbh |
Mahlhilfsmittel für die Röntgenfluoreszenzanalyse
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
RU2230556C2
(ru)
|
1999-10-29 |
2004-06-20 |
Эро-Селтик, С.А. |
Препаративные формы гидрокодона с контролируемым высвобождением
|
EP1272181A2
(en)
|
2000-04-13 |
2003-01-08 |
Synthon B.V. |
Modified release formulations containing a hypnotic agent
|
US6596198B1
(en)
|
2000-04-28 |
2003-07-22 |
Albemarle Corporation |
Additive system for polymers in pellet form which provides proportioned stabilization and internal mold release characteristics
|
AU2002227383B2
(en)
|
2000-10-30 |
2004-07-08 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
DE10140139A1
(de)
*
|
2001-08-16 |
2003-03-27 |
Uhde Gmbh |
Verfahren zum Granulieren konzentrierter Lösungen, insbesondere zur Düngemittelherstellung, sowie Granulator zur Durchführung des Verfahrens
|
US9107804B2
(en)
|
2002-12-10 |
2015-08-18 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
EP1590144B1
(en)
*
|
2002-12-10 |
2015-07-29 |
Nortec Development Associates, Inc. |
Method of preparing biologically active formulations
|
WO2005123042A1
(en)
*
|
2004-06-10 |
2005-12-29 |
Glatt Air Techniques, Inc. |
Controlled release pharmaceutical formulation
|
DE102005042875A1
(de)
*
|
2004-12-23 |
2006-09-21 |
Grünenthal GmbH |
Schnell freisetzende Darreichungsformen für Antibiotika
|
DE102005019458A1
(de)
*
|
2005-04-25 |
2006-10-26 |
Grünenthal GmbH |
Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
|
EP1915137B8
(de)
|
2005-08-10 |
2013-09-11 |
ADD Advanced Drug Delivery Technologies, Ltd. |
Orales präparat mit kontrollierter freisetzung
|
CN101080252B
(zh)
*
|
2005-09-09 |
2010-10-13 |
宝洁公司 |
包含基于油包水乳液的多层的固体护肤组合物
|
US8148393B2
(en)
*
|
2005-11-18 |
2012-04-03 |
Synthon Bv |
Zolpidem tablets
|
JP2009520704A
(ja)
*
|
2005-12-21 |
2009-05-28 |
エーディーディー アドバンスト ドラッグ デリバリー テクノロジーズ リミテッド |
水溶性担体を持つコアを含むペレット
|
EP2068840A2
(en)
*
|
2006-07-21 |
2009-06-17 |
LAB International SRL |
Hydrophobic abuse deterrent delivery system
|
WO2009035969A1
(en)
*
|
2007-09-10 |
2009-03-19 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of sglt
|
US9056850B2
(en)
*
|
2008-10-17 |
2015-06-16 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
US20110009347A1
(en)
|
2009-07-08 |
2011-01-13 |
Yin Liang |
Combination therapy for the treatment of diabetes
|
EP2451797B1
(en)
|
2009-07-10 |
2013-04-03 |
Janssen Pharmaceutica, N.V. |
CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE
|
WO2011047113A1
(en)
*
|
2009-10-14 |
2011-04-21 |
Janssen Pharmaceutica Nv |
Process for the preparation of compounds useful as inhibitors of sglt2
|
CN108354930A
(zh)
|
2010-05-11 |
2018-08-03 |
詹森药业有限公司 |
包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的药物制剂
|
HUE030116T2
(en)
|
2011-04-13 |
2017-04-28 |
Janssen Pharmaceutica Nv |
A method for preparing compounds useful as inhibitors of SGLT2
|
TWI542596B
(zh)
|
2011-05-09 |
2016-07-21 |
健生藥品公司 |
(2s,3r,4r,5s,6r)-2-(3-((5-(4-氟苯基)噻吩-2-基)甲基)-4-甲基苯基)-6-(羥甲基)四氫-2h-哌喃-3,4,5-三醇之l-脯胺酸及檸檬酸共晶體
|
DE102012007671A1
(de)
*
|
2012-04-16 |
2013-10-17 |
Acino Pharma Ag |
Pellets mit hohem Wirkstoffgehalt
|
US20170071970A1
(en)
|
2015-09-15 |
2017-03-16 |
Janssen Pharmaceutica Nv |
Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
|
WO2017142867A1
(en)
|
2016-02-15 |
2017-08-24 |
Georgia-Pacific Chemicals Llc |
Extrusion additive manufacturing of pellets or filaments of thermosetting resins
|
EP3578599A1
(en)
|
2018-06-08 |
2019-12-11 |
Cytec Industries Inc. |
Granular stabilizer compositions for use in polymer resins and methods of making same
|